Select Medical Holdings Co. (NYSE:SEM) Director Marilyn B. Tavenner Sells 32,000 Shares

Select Medical Holdings Co. (NYSE:SEM) Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at $463,980. This represents a 59.26 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Select Medical Stock Up 3.7 %

Select Medical stock opened at $21.11 on Friday. The firm has a market cap of $2.73 billion, a price-to-earnings ratio of 9.86, a P/E/G ratio of 0.91 and a beta of 1.42. The firm has a fifty day moving average price of $34.11 and a two-hundred day moving average price of $34.71. Select Medical Holdings Co. has a fifty-two week low of $20.00 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.07. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.46 EPS. As a group, analysts forecast that Select Medical Holdings Co. will post 2.16 earnings per share for the current year.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s dividend payout ratio (DPR) is currently 23.36%.

Analysts Set New Price Targets

Several research analysts have recently commented on SEM shares. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Bank of America initiated coverage on shares of Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price on the stock. Royal Bank of Canada boosted their price target on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Finally, StockNews.com lowered Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Select Medical presently has a consensus rating of “Hold” and a consensus target price of $40.75.

Institutional Trading of Select Medical

A number of hedge funds have recently bought and sold shares of the stock. Hexagon Capital Partners LLC raised its position in shares of Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after buying an additional 645 shares during the last quarter. Quarry LP bought a new position in Select Medical during the third quarter valued at about $30,000. Transcendent Capital Group LLC acquired a new position in Select Medical in the 2nd quarter valued at approximately $35,000. Canada Pension Plan Investment Board bought a new stake in shares of Select Medical in the 2nd quarter worth approximately $39,000. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Select Medical during the second quarter valued at approximately $60,000. 89.48% of the stock is owned by institutional investors.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.